Why your peptide's COA doesn't tell the whole purity story

A July 2026 policy brief from the Information Technology and Innovation Foundation argued that the FDA should tighten oversight of peptides added to compounded medications. The core concern: the testing documentation most suppliers provide falls well short of what pharmaceutical manufacturing requires. Whether or not you track regulatory debates, the same gaps that concern policymakers affect the reliability of what you're working with at your bench.

Why compounded peptides attracted regulatory attention

Compounding pharmacies are licensed facilities that prepare custom drug formulations. They operate under a different FDA framework than drug manufacturers, one that allows them to use bulk raw ingredients, including peptides, to make formulations unavailable commercially or in standard doses. For years, peptides moved through this channel without the identity and purity verification that an FDA-approved drug must demonstrate before reaching a pharmacy shelf.

The ITIF's argument is direct: adding a compound to a medication without verified identity, known purity, and confirmed potency creates an unacceptable unknown. The policy question concerns patients. The research question is parallel: if the testing documentation on your vial is thin, your experimental results rest on an assumption you can't confirm.

What a thorough purity test actually involves

Most supplier COAs show one number: HPLC purity. HPLC stands for high-performance liquid chromatography. The sample is pushed through a tube packed with fine particles, and different molecules travel at different speeds. The instrument measures what emerges and when, then calculates what percentage of the total is your target compound. A figure of 98% or higher is standard for research-grade peptides.

That number is useful but limited. HPLC purity tells you what fraction of the sample is "the peptide" by peak area. It doesn't confirm several things that matter:

• Amino acid sequence: Peptides are chains of amino acids assembled in a specific order. HPLC won't catch a synthesis error where one amino acid is swapped for another of similar mass and charge.
• Isomer form: Each amino acid exists in two mirror-image versions, called D and L. Biological peptides use L-forms. A batch that incorporates D-amino acids will produce the correct molecular weight on a mass spec read but behave differently than expected.
• Aggregation: Peptide molecules can clump together, especially during lyophilization (the freeze-drying process that converts a peptide solution into the powder you receive). Aggregates often don't appear as a separate HPLC peak.
• Endotoxins: These are fragments from bacterial cell walls that can interfere with cell-based assays. Detecting them requires a separate test (an LAL or recombinant factor C assay), not HPLC.

Mass spectrometry (MS) adds molecular weight confirmation and catches many sequence errors. But MS and HPLC together still don't cover endotoxins or aggregation. Each test answers a different question, and no single number answers all of them.

What complete sourcing documentation looks like

When evaluating a peptide supplier, look for a COA that includes HPLC purity, mass spectrometry data, and an endotoxin result stated as a specific limit in EU/mg or similar units. Suppliers that add amino acid analysis or full sequence confirmation provide the highest confidence level currently available for a synthetic peptide.

Batch-specific COAs matter more than general product pages. A COA tied to your lot number shows that specific production run was tested. A COA from a representative sample tested months earlier is a weaker claim. Ask for the lot-matched document if it isn't automatically provided.

Regulatory pressure tends to push better suppliers toward more detailed documentation. Watch for suppliers adding new test types rather than reformatting existing data to look more thorough.

Protecting your samples after reconstitution

Even a well-sourced peptide can degrade after reconstitution if the diluent or storage conditions aren't right. Bacteriostatic water (sterile water with 0.9% benzyl alcohol) slows microbial growth inside your vial between uses. That matters when you're drawing from the same vial across multiple sessions.

Reconstituted peptides held at refrigerator temperature (around 4°C) stay usable for a few weeks for most compounds. Freezer storage extends that, but repeated freeze-thaw cycles stress the peptide structure and shorten working life. Aliquoting, dividing your reconstituted stock into single-use portions before freezing, keeps each working volume to one thaw cycle.

Glass containers hold up better than plastic for most peptides. Glass doesn't leach plasticizers, and it gives the peptide fewer reactive surfaces to interact with over time. That's why 3 ml cartridges for the PreppinPeppers peptide pen are borosilicate glass, the same material pharmaceutical companies use for injectable-drug containers.

The regulatory conversation will run for years. Your sourcing decisions happen now. Knowing what a COA tests, and what it skips, is the fastest way to make a more informed call about what goes into your research vials.

Frequently asked questions

What does HPLC purity on a peptide COA actually measure?

HPLC purity shows what percentage of your sample is the target peptide by peak area. At 98%+ it meets research-grade standards, but it doesn't confirm amino acid sequence order, isomer form, aggregation, or endotoxin content.

What is bacteriostatic water and why use it to reconstitute peptides?

Bacteriostatic water is sterile water with 0.9% benzyl alcohol added. The benzyl alcohol slows microbial growth inside your vial between uses, extending the working life of reconstituted samples stored at 4°C.

What tests should a peptide COA include beyond HPLC purity?

Look for HPLC purity, mass spectrometry confirming molecular weight, and an endotoxin result in EU/mg. Full amino acid analysis or sequence confirmation adds the highest confidence level available for synthetic peptides.

Prompted by this coverage at Google News →

Related from our lab: the pen · cartridges · bacteriostatic water · reconstitution calculators

Shared by PreppinPeppers for research, educational, and demonstration awareness only. We link to third-party coverage; we do not endorse it, and nothing here is medical advice or a recommendation to use any substance in humans or animals. Our products are sold for laboratory research use only.

What the research community gets wrong about peptide certificates of analysis

A COA is a useful document, but it is easy to read more into it than the tests actually support. A few common mix-ups:

• A high HPLC number is not proof of identity. A 98% or 99% figure only says that most of the sample is one compound by peak area. It does not prove that compound is the exact sequence you ordered. Confirming the sequence needs separate methods like mass spectrometry and amino acid analysis.
• Purity and correct structure are different questions. A batch can hit a clean purity number and still carry the wrong isomer form (a D amino acid where an L was expected). The wrong form can read at the same molecular weight, so it slips past a quick check.
• A COA with no lot number tells you little about your vial. A result from a different production run is not a measurement of the powder in your hand. Ask for the document tied to your exact lot before you trust the numbers on it.
• Endotoxins never show up on an HPLC trace. A sample can look clean on HPLC and still carry endotoxin that can interfere with cell-based work. That needs its own test (an LAL or recombinant factor C assay), so a purity figure alone does not clear it.
• A COA describes the powder as tested, not your reconstituted stock. Once you add diluent and store the vial, aggregation and degradation can change the sample even when the starting document looked perfect. The COA is a snapshot at the factory, not a promise about your bench.

From our bench: If you have run one of your own peptide lots on HPLC, or sent a sample out for an independent endotoxin check, we want to hear what you found. Did your read match the purity figure the supplier printed, and did the lot number on the COA actually match the vial you received? Share the raw numbers you measured (not the ones on the paper) and we will fold real bench observations into future versions of this guide.

Sources

1. Bacteriostatic Water for Injection, USP , FDA/DailyMed label (0.9% benzyl alcohol)
2. Duerkop et al., Biotechnol J 2018 , Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation
3. Sigma-Aldrich (Merck) , Handling and Storage Guidelines for Peptides and Proteins
4. Benzyl alcohol, PubChem Compound record (CID 244)